Heartland Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100,000
Closed -$1.09M 216
2020
Q3
$1.09M Buy
+100,000
New +$791K 0.1% 190
2019
Q1
Sell
-550,000
Closed -$1.17M 198
2018
Q4
$1.17M Hold
550,000
0.1% 165
2018
Q3
$2.51M Sell
550,000
-200,000
-27% -$974K 0.17% 161
2018
Q2
$3.67M Sell
750,000
-157,424
-17% -$747K 0.24% 149
2018
Q1
$3.88M Sell
907,424
-19,642
-2% -$92.9K 0.26% 150
2017
Q4
$4.52M Hold
927,066
0.29% 131
2017
Q3
$4.03M Hold
927,066
0.26% 146
2017
Q2
$4.13M Buy
927,066
+7,066
+0.8% +$29.8K 0.27% 140
2017
Q1
$3.82M Buy
920,000
+70,000
+8% +$298K 0.23% 153
2016
Q4
$3.51M Buy
850,000
+120,000
+16% +$585K 0.19% 155
2016
Q3
$4.35M Buy
730,000
+630,000
+630% +$3.17M 0.25% 139
2016
Q2
$497K Buy
+100,000
New +$438K 0.03% 172

Other funds holding ASPN

Heartland Advisors's ASPN Position: Q4 2020 in Review

Heartland Advisors sold out of Aspen Aerogels (ASPN) in Q4 2020, closing a stake of 100,000 shares — an estimated $1.09M sold.

Heartland Advisors first reported a position in ASPN in Q2 2016 and held it in 12 quarters. The position peaked at $4.52M in Q4 2017. 76 funds tracked by Wall St. Rank hold ASPN as of Q4 2020.

  • Heartland Advisors reported no remaining Aspen Aerogels position as of Q4 2020 after selling out during the quarter.
  • Heartland Advisors sold 100,000 Aspen Aerogels shares in Q4 2020, an estimated $1.09M.
  • Heartland Advisors first reported a position in Aspen Aerogels in Q2 2016 and held it in 12 quarters.
  • Heartland Advisors's Aspen Aerogels position peaked at $4.52M in Q4 2017.
  • 76 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2020.

Based on Heartland Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.